Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treating Respiratory Emergencies in Children Study
NCT06074185Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jan 2024
- Primary completion
- Feb 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2 trial of ipratropium bromide and dexamethasone in asthma (2 arms), sponsored by Oregon Health & Science University. Primary endpoint: Proportion of Patients Admitted to the Hospital at 24 hours. Started Jan 2024; status: completed.
02
Drugs
ipratropium bromidedexamethasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06074185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06074185.